Pages that link to "Q26769917"
The following pages link to Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer (Q26769917):
Displaying 27 items.
- EIYMNVPV Motif is Essential for A1CF Nucleus Localization and A1CF (-8aa) Promotes Proliferation of MDA-MB-231 Cells via Up-Regulation of IL-6. (Q37050476) (← links)
- Hybrid Cells Derived from Human Breast Cancer Cells and Human Breast Epithelial Cells Exhibit Differential TLR4 and TLR9 Signaling. (Q38770438) (← links)
- Role of TOPK in lipopolysaccharide-induced breast cancer cell migration and invasion. (Q41092935) (← links)
- A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma. (Q41367937) (← links)
- The regulatory role of IL-6R in hepatitis B-associated fibrosis and cirrhosis (Q41663989) (← links)
- Tumor-related interleukins: old validated targets for new anti-cancer drug development (Q41716360) (← links)
- CBP501 suppresses macrophage induced cancer stem cell like features and metastases (Q41873851) (← links)
- Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer. (Q42121084) (← links)
- Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy (Q42288627) (← links)
- Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells (Q47104711) (← links)
- ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma (Q48651245) (← links)
- Equal Pro-inflammatory Profiles of CCLs, CXCLs, and Matrix Metalloproteinases in the Extracellular Microenvironment In Vivo in Human Dense Breast Tissue and Breast Cancer (Q49188109) (← links)
- Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling. (Q55308550) (← links)
- Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. (Q55396890) (← links)
- The Two-Faced Cytokine IL-6 in Host Defense and Diseases (Q59793706) (← links)
- The Interleukin-17 Family of Cytokines in Breast Cancer (Q60919599) (← links)
- MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer (Q64081418) (← links)
- The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells (Q64092190) (← links)
- HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β (Q64104807) (← links)
- Decreased expression of microRNA-30b promotes the development of pulpitis by upregulating the expression of interleukin-6 receptor (Q64280143) (← links)
- Blocking IL-6/GP130 Signaling Inhibits Cell Viability/Proliferation, Glycolysis, and Colony Forming Activity in Human Pancreatic Cancer Cells (Q88528893) (← links)
- Expression and clinical significance of serum amyloid A and interleukin-6 in patients with acute exacerbation of chronic obstructive pulmonary disease (Q89909396) (← links)
- Autophagy and Its Relationship to Epithelial to Mesenchymal Transition: When Autophagy Inhibition for Cancer Therapy Turns Counterproductive (Q90283205) (← links)
- Anticancer Activity of Tubulosine through Suppression of Interleukin-6-Induced Janus Kinase 2/Signal Transducer and Activation of Transcription 3 Signaling (Q90619852) (← links)
- If we build it they will come: targeting the immune response to breast cancer (Q91178274) (← links)
- Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer (Q91736923) (← links)
- Wikidata:Database reports/Constraint violations/P275 (← links | edit)